Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Evaluation of mRNA expression and DNA methylation status of immune checkpoints in the peripheral blood of COVID-19 patients.

Created on 18 Oct 2026

Authors

Ensie Sadat Mirsharif, Abdolrahman Rostamian, Mohammadreza Salehi, Nayere Askari, Tooba Ghazanfari

Published in

Epigenomics. Pages 1-14. Oct 18, 2026. Epub Oct 18, 2026.

Abstract

COVID-19 immunopathology involves dysregulated immune responses, partly mediated by inhibitory immune checkpoints (ICs). Epigenetic mechanisms, particularly DNA methylation by DNA methyltransferases (DNMTs), regulate gene expression. However, the interplay between IC transcription, promoter methylation, and DNMT expression across disease severities remains unclear.
This cross-sectional study enrolled 208 COVID-19 patients (mild to critical) and 93 healthy controls. mRNA expression of PDCD-1, HAVCR-2, LAG-3, CTLA-4, DNMT-1, DNMT-3a, and DNMT-3b was measured by RT qPCR after covariate adjustment. Promoter methylation of the four IC genes was assessed by MS-HRM in 90 patients and 24 controls.
COVID-19 patients showed significantly lower mRNA levels of PDCD-1, LAG-3, and CTLA-4 versus controls, with further reductions in hospitalized, ICU-admitted, and non-survivor subgroups. DNMT-1, DNMT-3a, and DNMT-3b transcripts were also markedly decreased. No significant methylation changes were observed for any of the four IC genes after FDR correction (all q >0.05).
Reduced DNMT transcripts suggest possible global hypomethylation, but no significant promoter methylation changes were detected for the IC genes examined. Whole-blood analysis and lack of protein/functional validation limit interpretation. This exploratory study provides a foundation for future cell-specific and prospective investigations into epigenetic-transcriptional crosstalk in COVID-19.

PMID:
42893387
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 23
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement